Skip to main content

Macular Degeneration Testing Offers Knowledge About the Genetic Risk Of AMD

By: Get News
Age-related Macular Degeneration (AMD) affects 11 million Americans. 70% of the cause is genetics. Twenty million Americans are at risk of AMD because of family history.

Visible Genomics and Scott Rediger are pleased to announce that they have created reliable macular degeneration testing to help understand the risk of macular degeneration and plan effective treatments. Age-Related Macular Degeneration (AMD) affects eleven million Americans. 70 percent of AMD cases are due to genetics. More than 20 million Americans are at risk of AMD because of their family history.  The heredity AMD genetic test provides a comprehensive risk assessment to provide advanced awareness of the risk of AMD.

Macular Degeneration is a progressive and degenerative disease that affects the central part of the retina, the macula. MD is the leading cause of irreversible vision loss in the U.S. Because the population is aging, the prevalence of AMD is increasing. Of the eleven million people who are diagnosed with AMD, 1.75 million have advanced forms of the disease.

Physicians can integrate genetic testing into the AMD protocol. The results of the testing can empower the physician and patient to make informed lifestyle and clinical decisions jointly. Actions taken can help to prevent or slow the course of the disease. Physicians who offer the testing provide greater access through easy, affordable and understandable genetic risk testing. The information in the test results allows the doctor to deliver personalized and preventative medications.

More details are available at

In the past, people who suffer from severe ocular disease have no awareness in advance of the risk of disease. They are diagnosed only after symptoms have progressed. The victims often have no understanding of the cause of the disease. They are not able to apply proactive measures to slow down or prevent the progression of the disease, which can mean vision loss. They often cannot afford genetic testing since many insurance plans will not cover testing. The mission of Visible Genomics is to arm individuals with the necessary information and prepare them for the future.

About the Company:

Visible Genomics provides genetic testing for AMD-risk patients. The team of professionals have combined decades of experience and high ethical standards to create Macular Degeneration genetic testing. Patients are helped to understand and prepare for eye health.

Media Contact
Company Name: Visible Genomics
Contact Person: Scott Rediger
Email: Send Email
Address:17W220 22nd St Ste 410
City: Oakbrook Terrace
State: IL 60181
Country: United States

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.